193 related articles for article (PubMed ID: 18421602)
21. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
Kim WK; Kwon YE
Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
[TBL] [Abstract][Full Text] [Related]
22. Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig.
Laurell G; Ekborn A; Viberg A; Canlon B
Audiol Neurootol; 2007; 12(3):170-8. PubMed ID: 17259704
[TBL] [Abstract][Full Text] [Related]
23. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model.
Thomas Dickey D; Muldoon LL; Kraemer DF; Neuwelt EA
Hear Res; 2004 Jul; 193(1-2):25-30. PubMed ID: 15219317
[TBL] [Abstract][Full Text] [Related]
24. [The role of mtDNA deletion in the sensitivity to aminoglycoside antibiotic induced deafness].
Kong W; Liu J; Dong J
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):94-7. PubMed ID: 12768661
[TBL] [Abstract][Full Text] [Related]
25. Delayed electrical stimulation and BDNF application following induced deafness in rats.
Song BN; Li YX; Han DM
Acta Otolaryngol; 2009 Feb; 129(2):142-54. PubMed ID: 18607918
[TBL] [Abstract][Full Text] [Related]
26. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
27. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity.
Nader ME; Théorêt Y; Saliba I
Laryngoscope; 2010 Jun; 120(6):1208-13. PubMed ID: 20513041
[TBL] [Abstract][Full Text] [Related]
28. Augmented ototoxic effect of cisplatin in heterozygotes of the German waltzing guinea pig.
Skjonsberg A; Bucinskaite V; Laurell G; Ulfendahl M
Audiol Neurootol; 2008; 13(2):97-104. PubMed ID: 18057873
[TBL] [Abstract][Full Text] [Related]
29. Ototoxic drugs: difference in sensitivity between mice and guinea pigs.
Poirrier AL; Van den Ackerveken P; Kim TS; Vandenbosch R; Nguyen L; Lefebvre PP; Malgrange B
Toxicol Lett; 2010 Mar; 193(1):41-9. PubMed ID: 20015469
[TBL] [Abstract][Full Text] [Related]
30. Ebselen attenuates cisplatin-induced ROS generation through Nrf2 activation in auditory cells.
Kim SJ; Park C; Han AL; Youn MJ; Lee JH; Kim Y; Kim ES; Kim HJ; Kim JK; Lee HK; Chung SY; So H; Park R
Hear Res; 2009 May; 251(1-2):70-82. PubMed ID: 19286452
[TBL] [Abstract][Full Text] [Related]
31. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
32. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
Fang B; Xiao H
Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
[TBL] [Abstract][Full Text] [Related]
33. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study.
Kim HH; Addison J; Suh E; Trune DR; Richter CP
Laryngoscope; 2007 Jul; 117(7):1209-15. PubMed ID: 17603319
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals.
Dehne N; Lautermann J; Petrat F; Rauen U; de Groot H
Toxicol Appl Pharmacol; 2001 Jul; 174(1):27-34. PubMed ID: 11437646
[TBL] [Abstract][Full Text] [Related]
35. Are intratympanic injections of N-acetylcysteine and methylprednisolone protective against Cisplatin-induced ototoxicity?
Saliba I; El Fata F; Ouelette V; Robitaille Y
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):236-43. PubMed ID: 20470667
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
37. Difluoromethylornithine-induced reversible hearing loss across a wide frequency range.
Smith MC; Tinling S; Doyle KJ
Laryngoscope; 2004 Jun; 114(6):1113-7. PubMed ID: 15179223
[TBL] [Abstract][Full Text] [Related]
38. Ototoxic effect of topical ciclopirox as an antimycotic preparation.
Baylancicek S; Serin GM; Ciprut A; Sari M; Akdaş F; Tutkun A
Otol Neurotol; 2008 Oct; 29(7):910-3. PubMed ID: 18698269
[TBL] [Abstract][Full Text] [Related]
39. Prevention of noise- and drug-induced hearing loss with D-methionine.
Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
[TBL] [Abstract][Full Text] [Related]
40. Accumulation, fractionation, and analysis of platinum in toxicologically affected tissues after cisplatin, oxaliplatin, and carboplatin administration.
Esteban-Fernández D; Verdaguer JM; Ramírez-Camacho R; Palacios MA; Gómez-Gómez MM
J Anal Toxicol; 2008 Mar; 32(2):140-6. PubMed ID: 18334097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
